ES8405386A1 - Un procedimiento para la preparacion de un derivado de tiazol. - Google Patents

Un procedimiento para la preparacion de un derivado de tiazol.

Info

Publication number
ES8405386A1
ES8405386A1 ES520791A ES520791A ES8405386A1 ES 8405386 A1 ES8405386 A1 ES 8405386A1 ES 520791 A ES520791 A ES 520791A ES 520791 A ES520791 A ES 520791A ES 8405386 A1 ES8405386 A1 ES 8405386A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
thiazole derivatives
ethenediamines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES520791A
Other languages
English (en)
Other versions
ES520791A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8405386A1 publication Critical patent/ES8405386A1/es
Publication of ES520791A0 publication Critical patent/ES520791A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/194Radicals derived from thio- or thiono carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
  • Earth Drilling (AREA)
  • Inert Electrodes (AREA)
  • Treating Waste Gases (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN DERIVADO DE TIAZOL, DE FORMULA (I), EN LA QUE R Y R SON HIDROGENO O ALQUILO C1-C4; R ES HIDROGENO O ALQUILO C1-C3; Z ES O, S O CH2; N ES 2 O 3; M ES 1, 2 O 3; R ES H O CH3; A ES N-CN, CH-NO2, S, O O NH; R ES ALQUILENO O ALQUINILO; Y R Y R SON H, CH3 O C2H5 Y SUS SALES FARMACEUTICAMENTE ACEPTABLES.CONSISTE EN HACER REACCIONAR UNA AMINA DE FORMULA (II) CON UN COMPUESTO DE FORMULA (I), EN LAS QUE W ES UN RADICAL; Y LOS RESTANTES SIMBOLOS TIENEN LOS SIGNIFICADOS YA MENCIONADOS.DE APLICACION EN EL TRATAMIENTO DE ULCERASPEPTICAS.
ES520791A 1982-03-19 1983-03-18 Un procedimiento para la preparacion de un derivado de tiazol. Granted ES520791A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/360,034 US4474794A (en) 1982-03-19 1982-03-19 N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds

Publications (2)

Publication Number Publication Date
ES8405386A1 true ES8405386A1 (es) 1984-06-01
ES520791A0 ES520791A0 (es) 1984-06-01

Family

ID=23416322

Family Applications (1)

Application Number Title Priority Date Filing Date
ES520791A Granted ES520791A0 (es) 1982-03-19 1983-03-18 Un procedimiento para la preparacion de un derivado de tiazol.

Country Status (22)

Country Link
US (1) US4474794A (es)
EP (1) EP0091220B1 (es)
JP (1) JPS58170773A (es)
KR (1) KR840004091A (es)
AT (1) ATE27156T1 (es)
AU (1) AU1254583A (es)
CA (1) CA1190547A (es)
CS (1) CS236788B2 (es)
DD (1) DD207376A5 (es)
DE (1) DE3371514D1 (es)
DK (1) DK91083A (es)
ES (1) ES520791A0 (es)
FI (1) FI830879L (es)
GB (1) GB2116973B (es)
GR (1) GR77882B (es)
IL (1) IL68152A0 (es)
NZ (1) NZ203605A (es)
PH (1) PH18504A (es)
PL (1) PL241066A1 (es)
PT (1) PT76397B (es)
RO (1) RO85385B (es)
ZA (1) ZA831882B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1277325C (en) * 1985-12-18 1990-12-04 Bruce A. Slomski Synthesis of nizatidine
ATE86619T1 (de) * 1987-04-06 1993-03-15 Heumann Pharma Gmbh & Co Verfahren zur herstellung von nitroethenderivaten.
NL9000132A (nl) * 1990-01-19 1991-08-16 Cedona Pharm Bv Nieuwe thiazoolderivaten.
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Also Published As

Publication number Publication date
PL241066A1 (en) 1985-01-02
EP0091220A2 (en) 1983-10-12
GB2116973B (en) 1985-08-29
IL68152A0 (en) 1983-06-15
AU1254583A (en) 1983-09-22
KR840004091A (ko) 1984-10-06
GB2116973A (en) 1983-10-05
CA1190547A (en) 1985-07-16
JPS58170773A (ja) 1983-10-07
FI830879L (fi) 1983-09-20
DK91083D0 (da) 1983-02-25
ATE27156T1 (de) 1987-05-15
PT76397A (en) 1983-04-01
PT76397B (en) 1986-02-04
FI830879A0 (fi) 1983-03-16
ZA831882B (en) 1984-11-28
EP0091220B1 (en) 1987-05-13
PH18504A (en) 1985-08-02
DD207376A5 (de) 1984-02-29
EP0091220A3 (en) 1984-05-23
DK91083A (da) 1983-09-20
CS236788B2 (en) 1985-05-15
GR77882B (es) 1984-09-25
RO85385A (ro) 1984-11-25
GB8307201D0 (en) 1983-04-20
NZ203605A (en) 1985-10-11
DE3371514D1 (en) 1987-06-19
US4474794A (en) 1984-10-02
RO85385B (ro) 1984-11-30
ES520791A0 (es) 1984-06-01

Similar Documents

Publication Publication Date Title
ES8306135A1 (es) "un procedimiento para la preparacion de un derivado de tiazol".
IL81609A0 (en) Substituted thienoimidazole derivatives,a process for their preparation,pharmaceutical compositions containing them,and their use as inhibitors of gastric acid secretion
IE940326L (en) Benzimidazole derivatives substituted with a radical group¹and their use for inhibiting gastric acid secretion
PT76831A (en) Process for preparing teichomycin a2 pure single factors 1,2,3,4 and 5 and of pharmaceutical compositions containing the same
DE3571984D1 (en) New substituted benzimidazoles, a process for their preparation and their use for inhibiting gastric acid secretion
IL67417A (en) Antiatherosclerotic substituted ureas,process for their preparation and pharmaceutical compositions containing them
IL70488A (en) 7(2-(difluoromethylthio)-acetylamino)-7-methoxy-3-tetrazolyl-thiomethyl-1-dethia-1-oxacephalosporins,processes for the preparation thereof and pharmaceutical and veterinary compositions containing the same
ES8405386A1 (es) Un procedimiento para la preparacion de un derivado de tiazol.
AR243167A1 (es) Procedimiento para la preparacion de toluidinas sustituidas.
HUT35653A (en) Process for preparing barbituric acid derivatives and anthelmintic compositions containing such compounds
IL87122A0 (en) Substituted thienoinidazole derivatives,process for the preparation thereof,pharmaceutical compositions containing them,and the use thereof as inhibitors of gastric acid secretion,as gastroprotectives and as medicaments for intestinal inflammations
PT76870B (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
IL77051A (en) Crystalline form of the monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide and pharmaceutical compositions containing it
IL104185A0 (en) Gastric acid secretion-inhibiting and gastrocyto-protective pharmaceutical compositions,novel famotidine salts and process for preparing same
ES8405794A1 (es) Procedimiento para la preparacion de nuevas piridobenzodiazepinonas
JPS57165373A (en) Guanidine derivative, manufacture and medicinal composition containing same for gastric acid secretion inhibition
PT76110B (en) Process for the preparation of 3,3-dialkyl indoline and 3,3-alkylene-indoline derivatives and of pharmaceutical compositions containing them
IL84548A0 (en) Substituted thienoimidazole-toluidine derivatives,a process for their preparation,pharmaceutical compositions containing them,and their use as inhibitors of gastric acid secretion
EP0256507A3 (en) 3-(1h-tetrazol-5-yl)oxanilic acid and salts thereof, method for preparing the same and pharmaceutical compositions containing the compound
IL67883A (en) 5's-(2r-butyl)-ergot peptide alkaloids and their salts,their production and pharmaceutical compositions containing them
IL87428A0 (en) Substituted thienoimidazole derivatives,processes for their preparation,pharmaceutical formulations containing them and their use as gastric acid secretion inhibitors
IL76837A0 (en) Benzimidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
ZA913175B (en) Heterocyclic compounds:2-styryl-4h-1-benzopyran-4-ones,process for their preparation and pharmaceutical compositions containing them
NZ226928A (en) Pyridyl-substituted thienoimidazole derivatives and pharmaceutical compositions
JPS57159769A (en) Guanidine derivative, manufacture and pharmaceutical composition containing same for gastric secretion inhibition